1. Azacitadine-related cutaneous vasculitis

   News item 28 October 2023 Pages: 1 - 1

2. Falsified Ozempic pens in the EU and UK

   News item 28 October 2023 Pages: 2 - 2

3. ICMRA statement on safety of COVID-19 vaccines

   News item 28 October 2023 Pages: 3 - 3

4. Warning against Haytox in Australia

   News item 28 October 2023 Pages: 4 - 4

5. Chemotherapy + ICIs in extensive-stage small-cell lung cancer: risk of interstitial lung disease

   Clinical study 28 October 2023 Pages: 5 - 5

6. Long-term PPIs after H. pylori eradication increases risk of gastric cancer

   Clinical study 28 October 2023 Pages: 6 - 6

7. No causal association between in utero levothyroxine exposure and seizures

   Clinical study 28 October 2023 Pages: 7 - 7

8. Novel method for deriving AE prevalence in RCTs

   Clinical study 28 October 2023 Pages: 8 - 8

9. Oxycodone allergies/intolerances: risk of worse postoperative pain, longer length of stay

   Clinical study 28 October 2023 Pages: 9 - 9

10. PD-1/PD-L1 inhibitor use for NSCLC: more irAEs with first-line therapy

    Clinical study 28 October 2023 Pages: 10 - 10

11. Postmarketing safety profile of brexanolone: many safety signals

    Clinical study 28 October 2023 Pages: 11 - 11

12. Risk of serious infections increases with tofacitinib versus bDMARDs

    Clinical study 28 October 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 28 October 2023 Pages: 13 - 13

14. Abacavir/dolutegravir/lamivudine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

    Case report 28 October 2023 Pages: 14 - 14

15. Aciclovir

    Case report 28 October 2023 Pages: 15 - 15

16. Acitretin/adalimumab/ciclosporin

    Case report 28 October 2023 Pages: 16 - 16

17. Acitretin/nicotinamide

    Case report 28 October 2023 Pages: 17 - 17

18. Adalimumab

    Case report 28 October 2023 Pages: 18 - 18

19. Adalimumab

    Case report 28 October 2023 Pages: 19 - 19

20. Adalimumab/ciclosporin/risankizumab

    Case report 28 October 2023 Pages: 20 - 20

21. Afatinib/ciprofloxacin/tetracycline

    Case report 28 October 2023 Pages: 21 - 21

22. Alendronic-acid

    Case report 28 October 2023 Pages: 22 - 22

23. Alprazolam/oxycodone

    Case report 28 October 2023 Pages: 23 - 23

24. Amantadine/levodopa/pergolide

    Case report 28 October 2023 Pages: 24 - 24

25. Amfetamine/enoxaparin-sodium

    Case report 28 October 2023 Pages: 25 - 25

26. Amfetamine/phencyclidine

    Case report 28 October 2023 Pages: 26 - 26

27. Aminolevulinic-acid

    Case report 28 October 2023 Pages: 27 - 27

28. Amiodarone

    Case report 28 October 2023 Pages: 28 - 28

29. Amiodarone

    Case report 28 October 2023 Pages: 29 - 29

30. Amiodarone/colestyramine

    Case report 28 October 2023 Pages: 30 - 30

31. Amiodarone/lidocaine/magnesium-sulfate

    Case report 28 October 2023 Pages: 31 - 31

32. Amitriptyline

    Case report 28 October 2023 Pages: 32 - 32

33. Amitriptyline

    Case report 28 October 2023 Pages: 33 - 33

34. Amphotericin-B/flucytosine

    Case report 28 October 2023 Pages: 34 - 34

35. Angelica-sinensis/cistanche/codonopsis-pilosula/eucommiae-ulmoides/ginseng/lycium-barbarum/paeonia-lactiflora/radix-angelicae-tuho/rhizoma-atractylodis/dexamethasone

    Case report 28 October 2023 Pages: 35 - 35

36. Antiasthmatics/magnesium

    Case report 28 October 2023 Pages: 36 - 36

37. Antibacterials

    Case report 28 October 2023 Pages: 37 - 37

38. Antibacterials

    Case report 28 October 2023 Pages: 38 - 38

39. Antibacterials

    Case report 28 October 2023 Pages: 39 - 39

40. Antibacterials

    Case report 28 October 2023 Pages: 40 - 40

41. Antibacterials/antifungals

    Case report 28 October 2023 Pages: 41 - 41

42. Antibacterials/immunosuppressants/steroids

    Case report 28 October 2023 Pages: 42 - 42

43. Antidepressants/antipsychotics/otilonium-bromide

    Case report 28 October 2023 Pages: 43 - 43

44. Antihyperglycaemics

    Case report 28 October 2023 Pages: 44 - 44

45. Antineoplastic

    Case report 28 October 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 28 October 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 28 October 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 28 October 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 28 October 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 28 October 2023 Pages: 50 - 50